First Page | Document Content | |
---|---|---|
![]() Date: 2016-01-31 16:48:21S&P/TSX 60 Index S&P/TSX Composite Index Valeant Pharmaceuticals Arbutin Skin whitening TSX Sirona Hydroquinone SBM Economy of Canada Economy Religion | Add to Reading List |
![]() | Filing under Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-12 of the Securities Exchange Act of 1934 Filing by: Media General, Inc. Subject Company: Media GeDocID: 1rtIs - View Document |
![]() | Translation October 29, 2015 Consolidated Financial Results for the Second Quarter of the Fiscal Year Ending March 31, 2016
DocID: 1rpqN - View Document |
![]() | Thomson Reuters Eikon Success StoryDocID: 1rp7s - View Document |
![]() | Fourth-Quarter and Full Year 2009 Results FOR IMMEDIATE RELEASE Highlights Growth in consolidated sales and operating segment income of 9.1% and 4.2% for full-year 2009, respectivelyDocID: 1rowq - View Document |
![]() | Microsoft Word - Keryx Biopharmaceuticals Inc. (KERX) - Initial Complaint.docxDocID: 1rk3U - View Document |